This is a demo store. No orders will be fulfilled.
首页
400-620-6333
免疫疾病靶点
选项
-
Recombinant Human IL-6R Protein种属: 人(Human) Accession #: P08887表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human IL-6 Protein at 2 μg/mL can bind Recombinant Human IL-6R Protein (rp147628) the EC50 is 8.0 - 24.0 ng/mL. 2. Measured by its ability to enhance the IL-6 activity on M1 mouse myeloid leukemia cells. The ED50 for this effect is typically 10.0 - 60.0 ng/mL.3. Using the Octet RED System, the affinity constant (Kd) of Recombinant Human IL-6R Protein (rp147628) bound Anti-IL6R Antibody was 0.1 nM.
-
Recombinant Human 4-1BB/TNFRSF9 Protein种属: 人(Human) Accession #: Q07011表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by its binding ability in a functional ELISA. Human 4-1BB/TNFRSF9 (rp169624) at 1.0 μg/mL can bind Urelumab (anti-TNFRSF9) (Ab170654) with the EC50 of 47.08 ng/mL.
-
Recombinant Bovine CD4 Protein种属: 牛(Bovine) Accession #: F1MJK4表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of NIH‑3T3 mouse embryonic fibroblast cells.The ED50for this effect is 0.1-0.5 μg/mL after a 1 hour incubation at37 °C.Optimal dilutions should be determined by each laboratory for each application.
-
Recombinant Human BCMA/TNFRSF17 Protein种属: 人(Human) Accession #: Q6PE46表达系统: HEK293 蛋白标签: C-hFc 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human BCMA/TNFRSF17 Protein (rp169554) at 0.5 μg/mL can bind Belantamab (anti-TNFRSF17) (Ab170526) with the EC50 of 22.0 ng/mL.
-
Recombinant Human CD79B Protein种属: 人(Human) Accession #: P40259表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL. 2. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
-
Recombinant Mouse CD40/TNFRSF5 Protein种属: 小鼠(Mouse) Accession #: P27512表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse CD40/TNFRSF5 is immobilized at 1 µg/mL (100 µL/well), the concentration of Recombinant Mouse CD40 Ligand/TNFSF5 that produces 50% optimal binding is found to be 100-600 ng/mL.
-
Recombinant Human TL1A/TNFSF15 Protein种属: 人(Human) Accession #: O95150表达系统: E. coli 蛋白标签: No tag 内毒素水平: <1.0 EU/μg生物活性: Measured by its ability to induce apoptosis of TF1 human erythroleukemic cells.The ED50 for this effect is typically 1.15 ng/mL.
-
Recombinant Human IL-7R alpha/CD127 Protein种属: 人(Human) Accession #: P16871表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human TSLP Protein (rp169653) at 2.0 μg/mL can bind Recombinant Human IL-7R alpha/CD127 Protein (rp181253) with the EC50 of 615.6 ng/mL.
-
Recombinant Mouse IL-1 RI Protein种属: 小鼠(Mouse) Accession #: P13504-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Approximately 0.005‑0.015 µg/mL of IL-1 sRI will inhibit 50% of the biological response due to 50 pg/mL of rmIL-1a.
-
Recombinant Human IL-6/IL-6R alpha Protein种属: 人(Human) Accession #: P08887,P05231表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit M1 mouse myeloid leukemia cell proliferation. The ED50 for this effect is 2.5-12.5 ng/mL.
-
Recombinant Mouse IL-23R Protein种属: 小鼠(Mouse) Accession #: Q8K4B4表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse IL-23 R is immobilized at 5 µg/mL (100 µL/well) the concentration of Recombinant Mouse IL‑23 that produces 50% of optimal binding response is approximately 5-25 ng/mL.
-
Recombinant Mouse IL-1Rrp2/IL-1R6 Protein种属: 小鼠(Mouse) Accession #: Q9ERS7表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. Immobilized rmIL-1F5, rmIL-1F6, or rmIL-1F8 at 1 µg/mL (100 µL/well) can bind rmIL-1 Rrp2/his with a linear range of 0.078-5 µg/mL.
